Search Results (154)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Immunogenicity in Clinical Practice and Drug Development: When is it Significant? | Academic Article |
Why?
|
| Understanding the relative roles of pharmacogenetics and ontogeny in pediatric drug development and regulatory science. | Academic Article |
Why?
|
| Leeder, J. Steven | Person |
Why?
|
| 2019 Drug Metabolism Gordon Research Conference Guiding Drug Development Using Translational ADME Science | Grant |
Why?
|
| Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond. | Academic Article |
Why?
|
| Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research. | Academic Article |
Why?
|
| Park, Taeju | Person |
Why?
|
| Pediatric pharmacokinetics: human development and drug disposition. | Academic Article |
Why?
|
| Toren, Paul | Person |
Why?
|
| Identifying genomic and developmental causes of adverse drug reactions in children. | Academic Article |
Why?
|
| Developmental pharmacology--drug disposition, action, and therapy in infants and children. | Academic Article |
Why?
|
| Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease. | Academic Article |
Why?
|
| Developmental aspects of drug metabolism in children | Academic Article |
Why?
|
| Ontogeny of Human Liver Aldehyde Oxidase: Developmental Changes and Implications for Drug Metabolism. | Academic Article |
Why?
|
| Effect of diet on the development of drug metabolism by cytochrome P-450 enzymes in healthy infants. | Academic Article |
Why?
|